Amenamevir Impurity 1 | CAS 59908-70-2 - Request Quote
Amenamevir Impurity 1
| SZ CAT No: | SZ-A213002 |
| CAS No | 59908-70-2 |
| Mol.F. | C8H7N3O |
| Mol.Wt. | 161.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1803608-48-1 (HCl salt) ; 1258651-20-5 (HBr salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Amenamevir Impurity 1 is chemically 4-(1,2,4-Oxadiazol-3-yl)aniline. Amenamevir Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Amenamevir Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Amenamevir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 59908-70-2
Purchase 59908-70-2
Order 59908-70-2
Enquire 59908-70-2
price of 59908-70-2
59908-70-2 Supplier
59908-70-2 Manufacturer
59908-70-2 Exporter
buy high quality Amenamevir Impurity 1
Purchase Amenamevir Impurity 1
Amenamevir Impurity 1 suppliers
Amenamevir Impurity 1 manufacturers
Amenamevir Impurity 1 price
Order Amenamevir Impurity 1
Enquire Amenamevir Impurity 1
Amenamevir Impurity 1 cost
Amenamevir Impurity 1 Supplier
Amenamevir Impurity 1 Distributor
Amenamevir Impurity 1 for Method Validation
Amenamevir Reference Standard
Amenamevir Impurity 1 for ANDA Filing
Amenamevir Impurity 1 for Forced Degradation Studies
Amenamevir Impurity 1 Identification Standards
Amenamevir Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.